A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants

NCT03346122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-64991524 Dose Level 1
DRUG: JNJ-64991524 Dose Level 2
DRUG: JNJ-64991524 Dose Level 3
DRUG: JNJ-64991524 Dose Level 4
DRUG: JNJ-64991524 Dose Level 5
DRUG: JNJ-64991524 Dose Level 6
DRUG: Placebo
DRUG: JNJ-64991524 Dose Level 7
DRUG: JNJ-64991524 Dose Level 8
DRUG: JNJ-64991524 Dose Level 9

Sponsor

Janssen Research & Development, LLC